Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.245 USD | +0.40% | -6.85% | -55.63% |
Apr. 03 | Stifel Cuts Price Target on Verve Therapeutics to $40 From $56, Maintains Buy Rating | MT |
Apr. 02 | Sector Update: Health Care Stocks Slide Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-55.63% | 520M | |
+0.74% | 42.59B | |
+6.48% | 40.65B | |
+47.75% | 40.57B | |
-11.96% | 26.77B | |
+6.99% | 24.81B | |
-24.73% | 18.17B | |
+27.79% | 12.05B | |
-3.81% | 11.7B | |
+7.59% | 11.1B |
- Stock Market
- Equities
- VERV Stock
- News Verve Therapeutics, Inc.
- Verve Therapeutics Names Allison Dorval as Finance Chief